CD44 is also known to modulate proliferation of numerous cell types, including breast cancer cells (Nam et al., 2015), lung cancer cells (Hu et al., 2018), and epithelial cells (Abbasi et al., 1993). This evidence concerns the gene CD44 and lung carcinoma.